HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kazumoto Murata Selected Research

Todralazine

2/2007A novel mechanism for drug-induced liver failure: inhibition of histone acetylation by hydralazine derivatives.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kazumoto Murata Research Topics

Disease

32Hepatocellular Carcinoma (Hepatoma)
05/2019 - 01/2002
18Infections
08/2022 - 08/2002
15Chronic Hepatitis C
05/2022 - 09/2002
14Neoplasms (Cancer)
01/2010 - 02/2002
9Liver Cirrhosis (Hepatic Cirrhosis)
07/2022 - 11/2002
7Hepatitis B
08/2021 - 11/2013
5Liver Diseases (Liver Disease)
08/2015 - 08/2004
5Fibrosis (Cirrhosis)
08/2015 - 03/2002
4Chronic Hepatitis B
07/2022 - 08/2002
4Disease Progression
12/2020 - 10/2012
3Hemorrhage
12/2020 - 09/2003
3Virus Diseases (Viral Diseases)
11/2013 - 10/2005
3Hypoxia (Hypoxemia)
10/2011 - 04/2007
3Autoimmune Diseases (Autoimmune Disease)
09/2007 - 09/2002
2Chronic Hepatitis (Chronic Active Hepatitis)
07/2022 - 10/2012
2Persistent Infection
05/2022 - 01/2014
2Inflammation (Inflammations)
09/2020 - 05/2019
2Colonic Neoplasms (Colon Cancer)
01/2018 - 04/2007
2Hepatitis C
11/2012 - 12/2006
2Neoplasm Metastasis (Metastasis)
12/2008 - 04/2007
2Thrombosis (Thrombus)
07/2008 - 03/2003
2Hepatitis
11/2005 - 01/2004
2Adenocarcinoma
01/2005 - 09/2002
2Esophageal and Gastric Varices (Esophageal Varices)
11/2003 - 09/2003
2Varicose Veins (Varicose Vein)
11/2003 - 11/2002
1Falciparum Malaria (Plasmodium falciparum Malaria)
05/2022
1Hepatitis A (Hepatitis, Infectious)
01/2022
1Heartburn (Pyrosis)
10/2021
1Seasonal Allergic Rhinitis (Hay Fever)
10/2021
1Drug Hypersensitivity (Drug Allergy)
10/2021
1Eosinophilic Esophagitis
10/2021
1Stomach Neoplasms (Stomach Cancer)
12/2020
1Ulcer
12/2020
1Intestinal Polyposis (Polyposis, Intestinal)
09/2020
1Gastric Polyposis
09/2020
1Malnutrition (Nutritional Deficiencies)
09/2020
1Hepatitis E
01/2020

Drug/Important Bio-Agent (IBA)

15InterferonsIBA
04/2022 - 08/2002
10Proteins (Proteins, Gene)FDA Link
08/2021 - 05/2003
7Tumor Biomarkers (Tumor Markers)IBA
10/2011 - 03/2002
6RNA (Ribonucleic Acid)IBA
01/2022 - 03/2005
6Antiviral Agents (Antivirals)IBA
03/2020 - 03/2005
6Ribavirin (Virazole)FDA LinkGeneric
08/2015 - 03/2005
5acarboxyprothrombin (PIVKA)IBA
01/2010 - 03/2002
5NF-kappa B (NF-kB)IBA
07/2008 - 09/2002
4Hepatitis B Surface Antigens (HBsAg)FDA Link
07/2022 - 01/2014
4Pharmaceutical PreparationsIBA
01/2022 - 01/2005
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2013 - 01/2002
3Immunoglobulin G (IgG)IBA
08/2022 - 09/2007
3Interferon LambdaIBA
07/2022 - 05/2019
3NucleotidesIBA
07/2022 - 01/2014
3NucleosidesIBA
07/2022 - 01/2018
3VaccinesIBA
01/2021 - 01/2003
3AntibodiesIBA
01/2018 - 08/2004
3Biomarkers (Surrogate Marker)IBA
08/2015 - 01/2005
3CytokinesIBA
11/2013 - 09/2002
3Interleukin-18 (Interleukin 18)IBA
07/2008 - 03/2005
3LigandsIBA
08/2005 - 09/2002
3PPAR gammaIBA
12/2003 - 01/2002
3Ethanol (Ethyl Alcohol)IBA
11/2003 - 02/2002
2entecavirFDA Link
07/2022 - 01/2018
2Tenofovir (Viread)FDA Link
07/2022 - 10/2020
2nasIBA
07/2022 - 01/2014
2Proton Pump InhibitorsIBA
10/2021 - 12/2020
21- (5- (2- fluorophenyl)- 1- (pyridin- 3- ylsulfonyl)- 1H- pyrrol- 3- yl)- N- methylmethanamineIBA
10/2021 - 12/2020
2DNA (Deoxyribonucleic Acid)IBA
08/2021 - 05/2003
2Interferon-alpha (Interferon Alfa)IBA
10/2020 - 03/2005
2Viral AntigensIBA
10/2020 - 02/2018
2Alanine Transaminase (SGPT)IBA
05/2019 - 08/2015
2Prothrombin (Factor II)IBA
04/2018 - 10/2011
2Aspartate Aminotransferases (Aspartate Transaminase)IBA
08/2015 - 10/2012
2Vitamin KFDA Link
11/2009 - 12/2008
2LaxativesIBA
09/2009 - 04/2009
2InterleukinsIBA
07/2008 - 03/2005
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2007 - 08/2004
2Hepatitis B e AntigensIBA
11/2005 - 08/2002
2Doxorubicin (Adriamycin)FDA LinkGeneric
05/2005 - 03/2003
2Cisplatin (Platino)FDA LinkGeneric
03/2005 - 03/2003
2Fluorouracil (Carac)FDA LinkGeneric
03/2005 - 03/2003
2CamptothecinIBA
01/2005 - 09/2002
2Death Domain ReceptorsIBA
07/2003 - 07/2003
2SHU 508 (Levovist)IBA
02/2003 - 07/2002
2alpha-Fetoproteins (alpha-Fetoprotein)IBA
03/2002 - 02/2002
1Nucleic AcidsIBA
08/2022
1adefovir dipivoxil (Hepsera)FDA Link
07/2022
1glecaprevir and pibrentasvirIBA
05/2022
1TabletsIBA
10/2021
1AllergensIBA
10/2021
1Immunoglobulin M (IgM)IBA
08/2021
1Adrenal Cortex Hormones (Corticosteroids)IBA
09/2020
1sodium-bile acid cotransporterIBA
03/2020
1Circular DNAIBA
03/2020
1Phosphates (Orthophosphate)IBA
01/2020
1Carrier Proteins (Binding Protein)IBA
05/2019
1wisteria lectinIBA
05/2019

Therapy/Procedure

23Therapeutics
10/2020 - 02/2002
2Enema (Enemas)
09/2009 - 04/2009
2Drug Therapy (Chemotherapy)
03/2005 - 03/2003
2Sclerotherapy
09/2003 - 11/2002
1Plasma Exchange
05/2022